Loading…

Microscopy-based cellular contractility assay for adult, neonatal, and hiPSC cardiomyocytes

This protocol provides instructions to acquire high-quality cellular contractility data from adult, neonatal, and human induced pluripotent stem cell-derived cardiomyocytes. Contractility parameters are key to unravel mechanisms underlying cardiac pathologies, yet difficulties in acquiring data can...

Full description

Saved in:
Bibliographic Details
Published in:STAR protocols 2022-03, Vol.3 (1), p.101144, Article 101144
Main Authors: Scalzo, Sérgio, Mendonça, Carolina A.T. F., Kushmerick, Christopher, Agero, Ubirajara, Guatimosim, Silvia
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This protocol provides instructions to acquire high-quality cellular contractility data from adult, neonatal, and human induced pluripotent stem cell-derived cardiomyocytes. Contractility parameters are key to unravel mechanisms underlying cardiac pathologies, yet difficulties in acquiring data can compromise measurement accuracy and reproducibility. We provide optimized steps for microscope and camera setup, as well as cellular selection criteria for different cardiomyocyte cell types, aiming to obtain robust and reliable data. Moreover, we use CONTRACTIONWAVE software to analyze and show the optimized results. For complete details on the use and execution of this profile, please refer to Scalzo et al. (2021). [Display omitted] •High-quality contractility data requires specific settings for different cardiac cells•Distinct cell types require specific selection criteria for proper contractility assay•High-quality recordings require adjustments to focus, diaphragm, and lighting•Non-optimized data acquisition settings can influence cell contractility speed This protocol provides instructions to acquire high-quality cellular contractility data from adult, neonatal, and human induced pluripotent stem cell-derived cardiomyocytes. Contractility parameters are key to unravel mechanisms underlying cardiac pathologies, yet difficulties in acquiring data can compromise measurement accuracy and reproducibility. We provide optimized steps for microscope and camera setup, as well as cellular selection criteria for different cardiomyocyte cell types, aiming to obtain robust and reliable data. Moreover, we use CONTRACTIONWAVE software to analyze and show the optimized results.
ISSN:2666-1667
2666-1667
DOI:10.1016/j.xpro.2022.101144